Enfield Development Finance: 1 Unit Residential Scheme at 12 Chester Road London N9 8JG Enters the Pipeline

A change of use application at 12 Chester Road, London N9 8JG has landed on the London Borough of Enfield's planning register, and it is the kind of small scheme our desk sees a lot of demand for right now. Application 26/03368/FUL, received on 10 August 2026, seeks to convert the property from a Use Class C3 dwelling house to a Use Class C4 house in multiple occupation, with associated amenity space, cycle and refuse storage, a single storey wraparound extension replacing an existing infill extension, a rear dormer converted to an outrigger dormer, and front roof lights. The application is pending decision.

It is a single unit scheme rather than a multi plot development, but per the planning register the numbers still stack up in a way worth flagging to sponsors. Our desk estimates a gross development value of around £445,000 once the conversion and extension works are complete, and that figure sits comfortably within the range where specialist commercial lenders and bridging specialists are actively quoting on HMO conversions across north London right now.

This scheme sits within a borough where we track applications regularly, and readers following the wider pipeline can see how Enfield's planning activity compares on our Enfield location page. Chester Road is a short walk from Lower Edmonton, and HMO conversions in this pocket of N9 tend to lean on strong rental demand rather than speculative sale value, which is exactly the profile lenders want to see before they commit funds.

On the finance side, a scheme like this typically needs two distinct facilities rather than one. The purchase and conversion works call for a short term bridging or development loan sized against cost, usually released in stages as the wraparound extension and dormer works progress. Once the property is let as a licensed HMO, that facility needs to be refinanced onto a term product, and the gap between the two, commonly called the development exit, is where schemes either save money or bleed it through extended bridging rates. With an estimated GDV of £445,000, the loan sizing on both sides of that bridge is modest enough that challenger banks will often compete directly with specialist lenders for the exit piece.

Our read is straightforward. A single unit HMO conversion of this size rarely struggles to attract interest, but the timeline matters more than sponsors expect. Enfield's decision process on C3 to C4 change of use applications can run to several months, and sponsors who wait until consent lands before approaching lenders lose time they cannot easily buy back. We would rather see funding terms agreed in principle now, with the facility structured to draw down the moment planning comes through, than have a workable scheme stall at the finish line over financing that should have been sorted months earlier.